Fund HoldingsSaturn V Capital Management LP

Total Portfolio Value
$249.42M
Total Bought
$72.81M
Total Sold
$101.84M
Net Transaction
-$29.04M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
VAXCYTE INC(PCVX)0185,175+185,175012,6495.07%+12,649
DISC MEDICINE INC(IRON)64,784254,803+190,0193,74215,8646.36%+12,122
ABIVAX SA(ABVX)0622,970+622,97008,9083.57%+8,908
IRONWOOD PHARMACEUTICALS INC0944,912+944,91208,2303.30%+8,230
AMICUS THERAPEUTICS INC
COM
199,973898,381+698,4082,83810,5834.24%+7,745
ARGENX SE(ARGX)51,17565,597+14,42219,46925,82710.35%+6,358
COGENT BIOSCIENCES INC(COGT)756,6811,595,021+838,3404,44910,7194.30%+6,269
MERUS N V389,333376,629-12,70410,70716,9606.80%+6,253
PHATHOM PHARMACEUTICALS INC(PHAT)160,075500,987+340,9121,4615,3202.13%+3,859
GERON CORP(GERN)01,123,995+1,123,99503,7091.49%+3,709
CABALETTA BIO INC0173,173+173,17302,9541.18%+2,954
CRINETICS PHARMACEUTICALS IN(CRNX)787,132660,143-126,98928,00630,90112.39%+2,895
AMBRX BIOPHARMA INC52,7810-52,7817520-752
ASCENDIS PHARMA A/S(ASND)131,759103,428-28,33116,59515,6356.27%-960
ANAPTYSBIO INC664,276586,031-78,24514,22913,1975.29%-1,031
BIOMARIN PHARMACEUTICAL INC(BMRN)119,188119,188011,49210,4104.17%-1,082
JASPER THERAPEUTICS INC1,386,2150-1,386,2151,0940-1,094
SYNDAX PHARMACEUTICALS INC(SNDX)518,799397,997-120,80211,2119,4723.80%-1,739
ALNYLAM PHARMACEUTICALS INC(ALNY)10,3270-10,3271,9770-1,977
MORPHIC HLDG INC212,34385,632-126,7116,1323,0141.21%-3,118
ITEOS THERAPEUTICS INC828,232387,095-441,1379,0695,2802.12%-3,789
APELLIS PHARMACEUTICALS INC
COM
142,92771,463-71,4648,5564,2011.68%-4,355
KALVISTA PHARMACEUTICALS INC1,807,5631,441,952-365,61122,14317,1026.86%-5,041
ASTRIA THERAPEUTICS INC990,6630-990,6637,6080-7,608
BIOGEN INC(BIIB)32,4690-32,4698,4020-8,402
AMYLYX PHARMACEUTICALS INC(AMLX)1,099,2680-1,099,26816,1810-16,181
CYMABAY THERAPEUTICS INC750,2500-750,25017,7210-17,721
CYTOKINETICS INC(CYTK)448,144263,701-184,44337,41618,4887.41%-18,927
Page 1 of 1